首页> 外文学位 >Association between taking asthma medication and total direct healthcare costs among patients with asthma
【24h】

Association between taking asthma medication and total direct healthcare costs among patients with asthma

机译:哮喘患者服用哮喘药物与直接医疗总费用之间的关联

获取原文
获取原文并翻译 | 示例

摘要

Asthma is one of the most common chronic and financially burdensome diseases in the United States. Previous studies have focused on comparing healthcare costs between asthma patients and non-asthma patients. This study is unique as it compares healthcare costs among asthma patients based on whether they take daily asthma medication. In addition, this cross-sectional study investigates whether the daily asthma medication-healthcare cost association differs by age or race/ethnicity. Medical Expenditure Panel Survey (MEPS) 2012-2013 data was used for this secondary data analysis (n=1,336). Prescription taking status and total healthcare costs were self-reported by the study participants. A two part linear regression model was used to calculate total healthcare costs for the asthma patients. Healthcare costs for patients taking daily asthma prescriptions were higher than for patients not taking daily asthma prescriptions ($15,149 vs $7,485; p ≤ 0.0001) after controlling for confounders. Race/ethnicity and age were effect modifiers of the association. Additional studies are needed to investigate possible factors associated with these higher costs. Specifically, future studies should further evaluate the racial/ethnic and age disparities seen in this study. This information could assist medical and public health practitioners in better understanding some of the issues responsible for high healthcare costs and helping them to plan strategies to minimize these costs among asthma patients.
机译:哮喘是美国最常见的慢性疾病和经济负担大的疾病之一。先前的研究集中在比较哮喘患者和非哮喘患者之间的医疗保健费用。这项研究是独特的,因为它根据哮喘患者是否每天服用哮喘药物来比较他们的医疗费用。此外,这项横断面研究调查了每日哮喘药物与医疗保健费用的关联是否因年龄或种族/民族而有所不同。医疗费用小组调查(MEPS)2012-2013数据用于该次要数据分析(n = 1,336)。处方服用状态和总医疗费用由研究参与者自行报告。使用两部分线性回归模型来计算哮喘患者的总医疗费用。在控制了混杂因素之后,每日服用哮喘处方的患者的医疗保健费用高于未服用每日哮喘处方的患者($ 15,149 vs $ 7,485; p≤0.0001)。种族/民族和年龄是协会的影响因子。需要进行其他研究以调查与这些较高成本相关的可能因素。具体而言,未来的研究应进一步评估本研究中发现的种族/族裔和年龄差异。这些信息可以帮助医学和公共卫生从业人员更好地理解造成高昂医疗费用的一些问题,并帮助他们制定策略以使哮喘患者中的这些费用降至最低。

著录项

  • 作者

    Dave, Ira.;

  • 作者单位

    The University of North Carolina at Charlotte.;

  • 授予单位 The University of North Carolina at Charlotte.;
  • 学科 Public health.
  • 学位 M.S.
  • 年度 2016
  • 页码 48 p.
  • 总页数 48
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号